Alberto Ortíz

Active 1993–2026

Also published as
Alberto Ortiz
522
Papers
39,878
Citations
110
h-index
434
i10-index

Citations

Citations per year for Alberto Ortíz1967: 1 citations1994: 1 citations1995: 3 citations1996: 3 citations1997: 11 citations1998: 16 citations1999: 27 citations2000: 48 citations2001: 33 citations2002: 31 citations2003: 45 citations2004: 39 citations2005: 44 citations2006: 32 citations2007: 39 citations2008: 77 citations2009: 103 citations2010: 146 citations2011: 168 citations2012: 164 citations2013: 205 citations2014: 238 citations2015: 250 citations2016: 292 citations2017: 341 citations2018: 374 citations2019: 1,109 citations2020: 1,569 citations2021: 1,779 citations2022: 1,631 citations2023: 1,318 citations2024: 2,384 citations2025: 1,372 citations2026: 38 citations1968–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 2,874 citing papers, 16.8% of this breakdownUnited States: 2,524 citing papers, 14.8% of this breakdownSpain: 1,024 citing papers, 6% of this breakdownUnited Kingdom: 905 citing papers, 5.3% of this breakdownItaly: 865 citing papers, 5.1% of this breakdownGermany: 841 citing papers, 4.9% of this breakdownFrance: 558 citing papers, 3.3% of this breakdownNetherlands: 453 citing papers, 2.6% of this breakdownAustralia: 433 citing papers, 2.5% of this breakdownCanada: 413 citing papers, 2.4% of this breakdownJapan: 404 citing papers, 2.4% of this breakdownIndia: 305 citing papers, 1.8% of this breakdown
0%16.8%Other 32.1%

Fields

  • Medicine58.1%
  • Biochemistry, Genetics and Molecular Biology18.6%
  • Engineering7.4%
  • Computer Science4.7%
  • Immunology and Microbiology3.2%
  • Agricultural and Biological Sciences1.5%
  • Other6.5%

Topics

  • Chronic Kidney Disease and Diabetes5.3%
  • Dialysis and Renal Disease Management3.8%
  • Robotics and Sensor-Based Localization2.3%
  • Acute Kidney Injury Research2.1%
  • Renal Diseases and Glomerulopathies2%
  • Diabetes Treatment and Management1.6%
  • Other82.9%

Coauthors

All papers

Open in search
  1. Chronic kidney disease and the global public health agenda: an international consensus

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Reviews Nephrology 2024 cited by 1,125

  2. Targeting the progression of chronic kidney disease

    Authors: , , , , - Nature Reviews Nephrology 2020 cited by 965

  3. Regulated cell death pathways in kidney disease

    Authors: , , , - Nature Reviews Nephrology 2023 cited by 354

  4. Ferroptosis, but Not Necroptosis, Is Important in Nephrotoxic Folic Acid–Induced AKI

    Authors: , , , , , , , , , , - Journal of the American Society of Nephrology 2016 cited by 565

  5. Targeting inflammation to treat diabetic kidney disease: the road to 2030

    Authors: , , , , , , , , - Kidney International 2022 cited by 345

  6. The Role of PGC-1α and Mitochondrial Biogenesis in Kidney Diseases

    Authors: , , , , , , , , - Biomolecules 2020 cited by 282

  7. Fabry disease revisited: Management and treatment recommendations for adult patients

    Authors: , , , , , , , , , , , , , - Molecular Genetics and Metabolism 2018 cited by 644

  8. Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis‐mediated cell death

    Authors: , , , , , , , , , , , , , , - The FASEB Journal 2019 cited by 266

  9. The systemic nature of CKD

    Authors: , , , , , , , , , , , , , , , - Nature Reviews Nephrology 2017 cited by 438

  10. Inflammation in Diabetic Kidney Disease

    Authors: , , , , , - ˜The œNephron journals/Nephron journals 2018 cited by 300

  11. Atherosclerosis in Chronic Kidney Disease

    Authors: , , , , , , , - Arteriosclerosis Thrombosis and Vascular Biology 2019 cited by 301

  12. NF-κB in Renal Inflammation

    Authors: , , , , , , , - Journal of the American Society of Nephrology 2010 cited by 558

  13. Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Goce Spasovski, Marijn M. Speeckaert, Matias Trillini, Petra Zürbig, Heiko von der Leyen, Peter Rossing, Silke Zimmermann, Brit Rädisch, Anika Hävemeier, Annette Busmann, Ulrike Wittkop, Barbara Neuhaus, Regina Ax-Smolarski, Veit Zieglschmid, Eva Bollweber, Heidrun Wölk, Viktor Rotbain Curovic, Ninna Hahn Tougaard, Mie K. Eickhoff, Sascha Pilemann-Lyberg, Signe Abitz Winther, Signe Rosenlund, Tine W. Hansen, Bernt Johan von Scholten, Christian Stevns Hansen, Emilie H. Zobel, Jens Christian Laursen, Simone Theilade, Lone Jelstrup, Tina R. Juhl, Dorthe Riis, Jessie A. Hermann, Anne G. Lundgaard, Maja L.D. Halkjær, Lene Aabo, Therese Frost Lerche, Maria Lajer, Rikke J. Stefansen, Maria Campbell, Annika Durban, Julia Raad, Michael J. Prigge, Marco Schiemann, Robbie Wilson, Sharon Kean, Elizabeth Douglas, Pamela Surtees, Christina M. Gant, Stanley M.H. Yeung, Ilse J. M. Hagedoorn, Joanne Flynn, Joe Galloway, Katriona Brooksbank, Carolina Aparicio, Ilian Iliev, Francesco Nones, Francesca Lo Bue, Daniela Melacini, Daniela Cugini, Silvia Prandini, Verusca Lecchi, Svitlana Yakymchuk, Giulia Gherardi, Alessandro Villa, Davide Villa, Flavio Gaspari, Antonio Cannatà, Silvia Ferrari, Nadia Stucchi, Šárka Albrechtová and 31 more - The Lancet Diabetes & Endocrinology 2020 cited by 254

  14. The impact of population ageing on the burden of chronic kidney disease

    Authors: , , , , - Nature Reviews Nephrology 2024 cited by 148

  15. Two independent pathways of regulated necrosis mediate ischemia–reperfusion injury

    Authors: , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 561

  16. EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors

    Authors: , , , - Clinical Kidney Journal 2023 cited by 112

  17. The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manuel Praga, Manuel Praga, Ángel Sevillano, Fernando Caravaca‐Fontán, Hernando Trujillo, Eduardo Gutiérrez, Gema Fernández Juárez, Amir Shabaka, Jorge Rojas-Rivera, Jesús Egido, Alberto Ortíz, Marián Goicoechea, Úrsula Verdalles, Alfons Segarra, Irene Agraz, Guillermo Martín-Reyes, Lara Perea, Ildefonso Valera, Mónica Martín, Virginia Cabello, Miguel Ángel Pérez Valdivia, Luís F. Quintana, Miquel Blasco, Mercedes Cao, Andrés López Muñíz, Ana Ávila, T Małek, Mario Espinosa, Cristina Rabasco, Montserrat Díaz, Iara daSilva, Jordi Bonet, Maruja Navarro, Juan Ramón Gomez-Martino, Begoña Rivas, Antolina Rodríguez-Moreno, C. Galéano, Ana Romera, Ana Huerta, E. Rodriguez-Paternina, Ana Vigil, Roberto Alcázar, Vicente Paraíso, V. Barrio, Jack F.M. Wetzels, Anne-Els van de Logt, Julia M. Hofstra - Kidney International 2020 cited by 238

  18. Data Sharing Under the General Data Protection Regulation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Goce Spasovski, Jan A. Staessen, Dimitrios Stamatialis, Peter Stenvinkel, Christoph Wanner, Stephen B. Williams, Faı̈ez Zannad, Carmine Zoccali, Raymond Vanholder - Hypertension 2021 cited by 130

  19. Protective Role of Nrf2 in Renal Disease

    Authors: , , , , , , , , , , , , , , - Antioxidants 2020 cited by 116

  20. Tubular Mitochondrial Dysfunction, Oxidative Stress, and Progression of Chronic Kidney Disease

    Authors: , , , , , , , , - Antioxidants 2022 cited by 112

  21. Lipid management in patients with chronic kidney disease

    Authors: , , , , , , , , , , , , , , , - Nature Reviews Nephrology 2018 cited by 275

  22. iBoW-LCD: An Appearance-Based Loop-Closure Detection Approach Using Incremental Bags of Binary Words

    Authors: , - IEEE Robotics and Automation Letters, IEEE Robotics Autom. Lett. 2018 cited by 165

  23. RICORS2040: the need for collaborative research in chronic kidney disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Domingo Hernández Marrero, Constantino Fondevila Campo, Eduardo Miñambres García, Dolores García- Cosío Carmona, Armando Torres Ramírez, Luis Muñoz Bellvis, Marina Berenguer Haym, Manuel Barrera Gómez, José M. Cifrián, Josep María Cruzado Garrit, Rafael San Juan Garrido, Javier Briceño Delgado, Marta Bodro Marimont, María O Valentín Muñoz, José Miguel Pérez Villares, Ángel Salvatierra Velázquez, Luis Almenar Bonet, Miguel Ángel Gómez‐Bravo, Francesc J Moreso Mateos, Manuel Muro Amador, Auxiliadora Mazuecos Blanca, J. A. Pons Miñano, Amado Andrés Belmonte, Amparo Solé Jover, Daniel Casanova Rituerto, Fernando Pardo Sánchez, María Dolores Arenas, Roberto Martín Hernández, Blanca Miranda Serrano, Alberto Ortiz Arduan, Ana B. Sanz, Adrián M. Ramos, Gina Córdoba‐David, Jorge García-Jiménez, Miguel Fontecha‐Barriuso, Juan Guerrero‐Mauvecin, Ana M. López-Diaz, María Dolores Sánchez-Niño, Lara Valiño‐Rivas, Leticia Cuarental, Marta Ribagorda, Aránzazu Pintor‐Chocano, Chiara Favero, Gloria Álvarez‐Llamas, Martín Cleary Catalina, Beatriz Fernández‐Fernández, María Vanessa Pérez-Gómez, Emma Raquel Alegre de Montaner, Raúl Fernández Prado, Jorge Rojas Rivera, Ana María Ramos Verde, Sergio Luis‐Lima, Jinny Sánchez-Rodríguez, Soledad Pizarro Sánchez, Marta Ruiz‐Ortega, Emilio González Parra, Sandra Rayego Mateos, Pablo Javier Cannata Ortíz, Laura Márquez Expósito, Antonio Tejera‐Muñoz, Vanessa Marchant, Lucía Tejedor-Santamaria, Matilde Alique Agilar, Fritz Diekmann, Beatriz Bayés Genís, Federico Oppenheimer Salinas, María José Ramírez-Bajo, Elisenda Bañon Maneus, Marta Arias Guillén, Jordi Rovira Juárez and 309 more - Clinical Kidney Journal 2021 cited by 123

  24. Role of Macrophages and Related Cytokines in Kidney Disease

    Authors: , , , , , , , , , , , , , - Frontiers in Medicine 2021 cited by 119